FDA Inspection
BioEclipse Therapeutics, Inc.BioEclipse Therapeutics, Inc. – FDA Inspection, Mar 25, 2025
Record Details
This FDA Inspection record concerns BioEclipse Therapeutics, Inc., with an inspection on March 25, 2025, issued by the San Francisco District Office, covering biologics.
View Company Profile
ID · dc212f11-2dc0-4d60-835a-d37928abaaa0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1265444
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 312.50General responsibilities of sponsors
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.